EPOS primary care guidelines: European Position Paper on the primary care diagnosis and management of Rhinosinusitis and Nasal Polyps 2007 - A summary

Primary Care Respiratory Journal

Volumn 17, Issue 2, 2008, Pages 79-89

  Thomas, Mike ^a   Yawn, Barbara ^b   Price, David ^a   Lund, Valerie ^c   Mullol, Jocquim ^d   Fokkens, Wytske ^e  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d HOSPITAL CLÍNIC   (Spain)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Antibiotics; Corticosteroids; Epidemiology; Guideline; Management; Nasal polyps; Primary care; Rhinosinusitis

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIHISTAMINIC AGENT; BUDESONIDE; CEPHALOSPORIN DERIVATIVE; CORTICOSTEROID; DECONGESTIVE AGENT; ERYTHROMYCIN; IMMUNOMODULATING AGENT; IMMUNOSTIMULATING AGENT; MACROLIDE; MINOCYCLINE; MOMETASONE FUROATE; MUCOLYTIC AGENT; OXYMETAZOLINE; PENICILLIN G; PENICILLIN V; PROTON PUMP INHIBITOR; STEROID; XYLOMETAZOLINE;

ANTERIOR RHINOSCOPY; BONE DISEASE; CLINICAL PRACTICE; DISEASE SEVERITY; ENDOSCOPY; EPISTAXIS; EVIDENCE BASED MEDICINE; EYE TOXICITY; FACE PAIN; GENERAL PRACTITIONER; GROWTH DISORDER; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEDICAL SPECIALIST; MONOTHERAPY; NOSE CONGESTION; NOSE OBSTRUCTION; NOSE POLYP; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; REVIEW; RHINOSINUSITIS; SIDE EFFECT; SMELLING DISORDER; SYMPTOMATOLOGY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EUROPE; HUMANS; NASAL POLYPS; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; RHINITIS; SINUSITIS;

EID: 45349094933     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.3132/pcrj.2008.00029     Document Type: Review

References (95)

1. Fokkens W, Lund V, Mullol J, on behalf of the European Position Paper on Rhinosinusitis and Nasal Polyps group. European Position Paper on Rhinosinusitis and Nasal Polyps 2007. Rhinology 2007;20(Suppl):1-136.
2. Lim M, Lew-Gor S, Darby Y, et al. The relationship between subjective assessment instruments in chronic rhinosinusitis. Rhinology 2007;45(2):144-7.
3. Slavin RG. Nasal polyps and sinusitis. JAMA 1997;278(22): 1849-54.
4. Sturgess JM, Chao J, Wong J, Aspin N, Turner JA. Cilia with defective radial spokes: a cause of human respiratory disease. N Engl J Med 1979;300(2):53-6.
5. Bhattacharyya Nl. The role of infection in chronic rhinosinusitis. Curr Allergy Asthma Rep 2002;2(6):500-06.
6. Zacharek MA, Krouse JH. The role of allergy in chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2003;11(3):196-200.
7. Jones NS. CT of the paranasal sinuses: a review of the correlation with clinical, surgical and histopathological findings. Clin Otolaryngol 2002;27(1):11-17.
8. Jones NS, Strobl A, Holland I. A study of the CT findings in 100 patients with rhinosinusitis and 100 controls. Clin Otolaryngol 1997;22(1):47-51.
9. Dykewicz MS. 7. Rhinitis and sinusitis. J Allergy Clin Immunol 2003;111(2 Suppl):S520-9.
10. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000;85(3):209-14.
11. Gwaltney JM, Jr., Jones JG, Kennedy DW. Medical management of sinusitis: educational goals and management guidelines. The International Conference on sinus Disease. Ann Otol Rhinol Laryngol Suppl 1995;167:22-30.
12. Leggett JE. Acute sinusitis. When-and when not-to prescribe antibiotics. Postgrad Med 2004;115(1):13-9.
13. Lindbaek M. Acute sinusitis: guide to selection of antibacterial therapy. Drugs 2004;64(8):805-19.
14. Varonen H, Savolainen S, Kunnamo I, Heikkinen R, Revonta M. Acute rhinosinusitis in primary care: a comparison of symptoms, signs , ultrasound, and radiography. Rhinology 2003;41(1):37-43.
15. Gwaltney JM, Jr . Acute community-acquired sinusitis. Clin Infect Dis 1996;23(6):1209-23.
16. Hoban D, Felmingham D. The PROTEKT surveillance study: antimicrobial susceptibility of Haemophilus influenzae and Moraxella catarrhalis from community-acquired respiratory tract infections. J Antimicrob Chemother 2002;50(Suppl S1):49-59.
17. Berg O, Carenfelt C, Kronval l G. Bacteriology of maxillary sinusitis in relation to character of inflammation and prior treatment. Scand J Infect Dis 1988;20(5):511-16.
18. Felmingham D, Feldman C, Hryniewicz W, et al. Surveillance of resistance in bacteria causing community-acquired respiratory tract infections. Clin Microbiol Infect 2002;8(Suppl 2):12-42.
19. Pedersen M, Sakakura Y, Winther B, Brofeldt S, Mygind N. Nasal mucociliary transport, number of ciliated cells, and beating pattern in naturally acquired common colds. Eur J Respir Dis Suppl 1983;128(Pt 1):355-65.
20. Karlsson G, Holmberg K. Does allergic rhinitis predispose to sinusitis? Acta Otolaryngol Suppl 1994;515:26-8.
21. Chen Y, Dales R, Lin M. The epidemiology of chronic rhinosinusitis in Canadians. Laryngoscope 2003;113(7):1199-205
22. Bousquet J, Van Cauwenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(5 Suppl):S147-334.
23. Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of allergic rhinitis. Prim Care Respir J 2006;15:58-70. doi: 10.1016/j.pcrj.2005.11.002
24. Jones NS, Carney AS, Davis A. The prevalence of allergic rhinosinusitis: a review. J Laryngol Otol 1998;112(11):1019-30.
25. Johansson L, Akerlund A, Holmberg K, Melen I, Bende M. Prevalence of nasal polyps in adults: the Skovde population- based study. Ann Otol Rhinol Laryngol 2003;112(7):625-9.
26. Johansson L, Akerlund A, Holmberg K, Melen I, Bende M. Prevalence of nasal polyps in adults: the Skovde population based study. Ann Otol Rhinol Laryngol 2003;112(7):625-9.
27. Klossek JM, Neukirch F, Pribil C, et al. Prevalence of nasal polyposis in France: A cross-sectional, case-control study. Allergy 2005;60(2):233-7.
28. Hedman J, Kaprio J, Poussa T, Nieminen MM. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study. Int J Epidemiol 1999;28(4):717-22.
29. Maresh MM Washburn A. Paranasal sinuses from birth to late adolescence. Clinical and roentgengraphic evidence of infection. Am J Dis Child 1940;60:841-61.
30. Kakish KS, Mahafza T, Batieha A, Ekteish F, Daoud A. Clinical sinusitis in children attending primary care centers. Pediatr Infect Dis J 2000;19(11):1071-4.
31. Chen Y, Li WX, Yu SZ, Qian WH. Chang-Ning epidemiological study of children's health: I: Passive smoking and children's respiratory diseases. Int J Epidemiol 1988;17(2):348-55.
32. Kvaerner KJ, Tambs K, Harris JR, Mair IW, Magnus P. Otitis media: relationship to tonsillitis, sinusitis and atopic diseases. Int J Pediatr Otorhinolaryngol 1996;35(2):127-41.
33. Incaudo GA. Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation. Clin Rev Allergy Immunol 2004;27(2):159-77.
34. Bhattacharyya N, Vyas DK, Fechner FP, Gliklich RE, Metson Rl. Tissue eosinophilia in chronic sinusitis: quantificationt echniques. Arch Otolaryngol Head Neck Surg 2001;127(9):1102-05.
35. Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000;85(3):209-14.
36. Bhattacharyya N. A comparison of symptom scores and radiographic staging systems in chronic rhinosinusitis. Am J Rhinol 2005;19(2):175-9.
37. Abdel-Hak B, Gunkel A, Kanonier G, Schrott-Fischer A, Ulmer H, Thumfart Wl. Ciliary beat frequency, olfaction and endoscopic sinus surgery. ORL J Otorhinolaryngol Relat Spec 1998;60(4):202-05.
38. Williams JW, Jr., Simel DL, Roberts L, Samsa GP. Clinical evaluation for sinusitis. Making the diagnosis by history and physical examination. Ann Intern Med 1992;117(9):705-10.
39. Symptom scores as measures of the severity of rhinitis. Clin Allergy 1988;18(1):29-37.
40. Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg 1997;123(11):1175-9.
41. Linder A. Jonas I, Mann W. Misleading x-ray diagnosis due to maxillary sinus asymmetries. Laryngol Rhinol Ot ol (Stuttg) 1976;55(11):905- 13.
42. Iinuma T, Hirota Y, Kase Y. Radio-opacity of the paranasal sinuses. Conventional views and CT. Rhinology 1994;32(3):134-6.
43. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: Comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116(6):1289-95.
44. Qvarnberg Y, Kantola O, Salo J, Toivanen M, Valtonen H, Vuori E. Influence of topical steroid treatment on maxillary sinusitis. Rhinology 1992;30(2):103-12.
45. Meltzer EO, Orgel HA, Backhaus JW, et al. Intranasal flunisolide spray as an adjunct to oral antibiotic therapy for sinusitis. J Allergy Clin Immunol 1993;92(6):812-23.
46. Barlan IB, Erkan E, Bakir M, Berrak S, Basaran MM. Intranasal budesonide spray as an adjunct to oral antibiotic therapy for acute sinusitis in children. Ann Allergy Asthma Immunol 1997;78(6):598-601.
47. Meltzer EO, Charous BL, Busse WW, Zinreich SJ, Lorber RR, Danzig MR. Added relief in the treatment of acute recurrent sinusitis with adjunctive mometasone furoate nasal spray. The Nasonex Sinusitis Group. J Allergy Clin Immunol 2000;106(4):630-7.
48. Dolor RJ, Witsell DL, Hellkamp AS, Williams JW, Jr., Califf RM, Simel DL. Comparison of cefuroxime with or without intranasal fluticasone for the treatment of rhinosinusitis. The C A F F S Trial : a randomized controlled trial. JAMA 2001;286(24):3097-105.
49. Nayak AS, Settipane GA, Pedinoff A, et al. Effective dose range of mometasone furoate nasal spray in the treatment of acute rhinosinusitis. Ann Allergy Asthma Immunol 2002;89(3):271-8.
50. Puhakka T, Makela MJ, Malmstrom K, et al. The common cold: effects of intranasal fluticasone propionate treatment. J Allergy Clin Immunol 1998;101(6 Pt 1):726-31.
51. Parikh A, Scadding GK, Darby Y, Baker RC. Topical corticosteroids in chronic rhinosinusitis: a randomized, double-blind, placebo-controlled trial using fluticasone propionate aqueous nasal spray. Rhinology 2001;39(2):75-9.
52. Lavigne F, Cameron L, Renzi PM, et al. Intrasinus administration of topical budesonide to allergic patients with chronic rhinosinusitis following surgery. Laryngoscope 2002;112(5):858-64.
53. Cuenant G, Stipon JP , Plante - Longchamp G, Baudoin C, Guerrier Y. Efficacy of endonasal neomycin-tixocortolpivalate irrigation in the treatment of chronic allergic and bacterial sinusitis. ORL J Otorhinolaryngol Relat Spec 1986;48(4):226-32.
54. Sykes DA, Wilson R, Chan KL, Mackay IS, Cole PJ. Relative importance of antibiotic and improved clearance in topical treatment of chronic mucopurulent rhinosinusitis. A controlled study. Lancet 1986;2(8503):359-60.
55. Lund VJ, Black JH, Szabo LZ, Schrewelius C, Akerlund A. Efficacy and tolerability of budesonide aqueous nasal spray in chronic rhinosinusitis patients. Rhinology 2004;42(2):57-62.
56. Mygind N, Pedersen CB, Prytz S, Sorensen H. Treatment of nasal polyps with intranasal beclomethasone dipropionate aerosol. Clin Allergy 1975;5(2):159-64.
57. Deuschl H, Drettner B. Nasal polyps treated by beclomethasone nasal aerosol. Rhinology 1977;15(1):17-23.
58. Holopainen E, Grahne B, Malmberg H, Makinien J, Lindqvist N. Budesonide in the treatment of nasal polyposis. Eur J Respir Dis Suppl 1982;122:221-8.
59. Hissaria P, Smith W, Wormald PJ, et al. Short course of systemic coricosteroids in sinonasal polyposis: A double-blind randomized placebo-controlled triam with evaluation of outcome measures. J Allergy Clin Immunol 2006;118(1):128-33.
60. Benitez P, Alobid I, De Haro J, et al. A short course of oral prednisolone followed by nasal budesonide is an effective treatment of severe nasal polyps. Laryngoscope 2006;116(5):770-5.
61. Holm AF, Fokkens WJ, Godthelp T, Mulder PG, Vroom TM, Rijntjes E. A 1-year placebo-controlled study of intranasal fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis: a safety and biopsy study. Clin Otolaryngol 1998;23(1):69-73.
62. Salib RJ, Howarth PH. Safety and tolerabillity profile of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis. Drug Saf 2003;26(12):863-93.
63. Skoner D. Update of growth effects of inhaled and intranasal corticosteroids. Curr Opin Allergy Clin Immunol 2002;2(1):7-10.
64. Williams Jr JW, Aguilar C, Cornell J, et al. Antibiotics for acute maxillary sinusitis (Cochrane Review). Cochrane Database Syst Rev. 2003(4).
65. Ichimura K, Shimazaki Y, Ishibashi T, Higo R. Effect of new macrolide roxithromycin upon nasal polyps associated with chronic sinusitis. Auris Nasus Larynx 1996;23:48-56.
66. Hashiba M, Baba S. Efficacy of long-term administration of clarithromycin in the treatment of intractable chronic sinusitis. Acta Otolaryngol Suppl 1996;525:73-8.
67. Gandhi A, Brodsky L, Ballow M. Benefits of antibiotic prophylaxis in children with chronic sinusitis: assessment of outcome predictors. Allergy Proc 1993;14(1):37-43.
68. Ragab SM, Lund VJ, Scadding G. Evaluation of the medical and surgical treatment of chronic rhinosinusitis:a prospective randomised controlled trial. Laryngoscope 2004;114(5):923-30.
69. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A. A double-blind randomized placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 2006;116(2):189-93.
70. Stringer SP, Mancuso AA, Avino AJ. Effect of a topical vasoconstrictor on computed tomography of paranasal sinus disease. Laryngoscope 1993;103(1 Pt 1):6-9.
71. Benammar-Englmaier M, Hallermeier JK, Englmaier B. Alpha- mimetic effects on nasal mucosa in magnetic resonance tomography. Digitale Bilddiagn 1990;10(2):46-50.
72. Westerveld GJ, Voss HP, van der Hee RM, et al. Inhibition of nitric oxide synthase by nasal decongestants. Eur Respir J 2000;16(3):437-44.
73. Inanli S, Ozturk O, Korkmaz M, Tutkun A, Batman C. The effects of topical agents of fluticasone propionate, oxymetazoline, and 3% and 0.9% sodium chloride solutions on mucociliary clearance in the therapy of acute bacterial rhinosinusitis in vivo. Laryngoscope 2002;112(2):320-5.
74. McCormick DP, John SD, Swischuk LE, Uchida T. A double-blind, placebo-controlled trial of decongestant-antihistamine for the treatment of sinusitis in children. Clin Pediatr (Phila) 1996;35(9):457-60.
75. Graf P, Enerdal J, Hallen H. Ten days' use of oxymetazoline nasal spray with or without benzalkonium chloride in patients with vasomotor rhinitis. Arch Otolaryngol Head Neck Surg 1999;125(10):1128-32.
76. Braun JJ, Alabert JP, Michel FB, et al. Adjunct effect of loratadine in the treatment of acute sinusitis in patients with allergic rhinitis. Allergy 1997;52(6):650-5.
77. Sederberg-Olsen JF, Sederberg-Olsen AE. Intranasal sodium cromoglycate in post-catarrhal hyperreactive rhinosinusitis: a double-blind placebo controlled trial. Rhinology 1989;27(4):251-5.
78. Haye R, Aanesen JP, Burtin B, Donnelly F, Duby C. The effect of cetirizine on symptoms and signs of nasal polyposis. J Laryngol Otol 1998;112(11):1042-6.
79. Khalil HS, Nunez DA. Functional endoscopic sinus surgery for chronic rhinosinusitis. Cochrane Database Syst Rev. 2006;3:CD004458.
80. Lang EE, Curran AJ, Patil N, Walsh RM, Rawluk D, Walsh MA. Intracranial complications of acute frontal sinusitis. Clin Otolaryngol 2001;26(6):452-7.
81. Healy GB. Chandler et al.: "The pathogenesis of orbital complications in acute sinusitis." (Laryngoscope 1970;80:1414-1428). Laryngoscope 1997;107(4):441-6.
82. Wald ER. Sinusitis in children. N Engl J Med 1992;326(5): 319-23.
83. Van Buchem FL, Peeters MF, Knottnerus JA. Maxillary sinusitis in children. Clin Otolaryngol 1992;17(1):49-53.
84. Morris P, Leach A. Antibiotics for persistent nasal discharge (rhinosinusitis) in children (Cochrane Review). Cochrane Database Syst Rev. 2002(4):CD001094
85. Clement PA, Bluestone CD, Gordts F, et al. Management of rhinosinusitis in children: consensus meeting, Brussels, Belgium, September 13, 1996. Arch Otolaryngol Head Neck Surg 1998;124(1):31-4.
86. Passalacqua G, Albano M, Canonica GW, et al. Inhaled and nasal corticosteroids: safety aspects. Allergy 2000;55(1):16-33.
87. Scadding GK. Corticosteroids in the treatment of pediatric allergic rhinitis. J Allergy Clin Immunol 2001;108(1 Suppl):S59-64.
88. Fokkens WJ, Cserhati E, dos Santos JM, et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Ann Allergy Asthma Immunol 2002;89(3):279-84.
89. Fokkens WJ, Scadding GK. Perennial rhinitis in the under 4s: a difficult problem to treat safely and effectively? A comparison of intranasal fluticasone propionate and ketotifen in the treatment of 2-4-year-old children with perennial rhinitis. Pediatr Allergy Immunol 2004;15(3):261-6.
90. Baena-Cagnani CE. Safety and tolerability of treatments for allergic rhinitis in children. Drug Saf 2004;27(12):883-98.
91. Senior BA, Kennedy DW, Tanabodee J, Kroger H, Hassab M, Lanza DC. Long-term impact of functional endoscopic sinus surgery on asthma. Otolaryngol Head Neck Surg 1999;121(1):66-8.
92. Ponikau JU, Sherris DA, Kephart GM, et al. Features of airway remodeling and eosinophilic inflammation in chronic rhinosinusitis: Is the histopathology similar to asthma? J Allergy Clin Immunol 2003;112(5):877-82.
93. Szczeklik A, Stevenson DD. Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111(5):913-21.
94. Batra PS, Kern RC, Tripathi A, et al. Outcome analysis of endoscopic sinus surgery in patients with nasal polyps and asthma. Laryngoscope 2003;113(10):1703-06.
95. Hurst JR, Wilkinson TM, Donaldson GC, Wedzicha JA. Upper airway symptoms and quality of life in chronic obstructive pulmonary disease (COPD). Respir Med 2004;98(8):767-70.